Acthera is a Swiss biotech start-up that develops an entirely novel targeted therapy technology based on Hard-Shelled Liposomes (HSLs). The proprietary technology has the potential to address the most critical challenge in drug development – creating more efficacious, safer drugs. Acthera is growing to become a fully integrated drug discovery and development biotechnology company. It is located in Basel, one of the best European research & development hubs.
Key information
- Chemicals / Pharmaceuticals
- 1 - 10 employees
- Peter-Merianstrasse 45, 4052 Basel
- Acthera Therapeutics AG
New jobs directly in your mailbox?
Currently, there are no job offers. Follow this company, and we’ll inform you by email as soon as new jobs become available.
No reviews yet
Help others by sharing your experience with this company as an employee or a candidate.